Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at http://www.fivestarequities.com/ and get exclusive access to our numerous stock reports.
Align Technology, Inc. (NASDAQ: ALGN) shares increased 0.38 percent to close at $58.19 a share Monday. The stock traded between $57.93 and $59.43 on volume of 1.71 million shares traded. The company reported net revenues were $164.5 million, an increase of 20.5 percent when compared to a year ago. Shares of Align Technology have gained approximately 110.0 percent year-to-date.
Get more information on Align Technology and free access to the in-depth equity report at:
pSivida Corp. (NASDAQ: PSDV) shares declined 5.23 percent to close at $2.72 a share Monday. The stock traded between $2.65 and $2.85 on volume 737,541 shares traded. The company recently announced that FDA has decided to not approve its NDA for ILUVIEN. Shares of pSivida have gained approximately 40.0 percent year-to-date.
Get more information on pSivida free access to the in-depth equity report at:
Tellabs, Inc. (NASDAQ: TLAB) shares gained 4.26 percent to close at $2.45 a share Monday. The stock traded between $2.43 and $2.48 on volume of 54.78 million shares traded. The company has agreed to be acquired by Marlin Equity Partners $2.45 per share in cash.
Get more information on Tellabs and free access to the in-depth equity report at:
WebMD Health Corp. (NASDAQ: WBMD) shares spiked 10.41 percent to close at $35.42 a share Monday. The stock traded between $31.68 and $36.22 on volume of 1.70 million shares traded. The company announced that it will repurchase all shares owned by Carl C. Icahn and certain of his affiliates at a purchase price of $32.08 per share. Shares of WebMD Health have gained approximately 150.0 percent year-to-date.
Get more information on WebMD Health and free access to the in-depth equity report at:
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Five Star Equities
Leave a comment...